Irinotecan Impurity 4

Product Description
CAT No.
ALN-I010018
CAS No.
121080-63-5
Mol. F.
C28H28N2O11
Mol. Wt.
568.5
Stock
Please Inquire
Product Overview
Technical Data
Reference
RFQ
Product Overview
Chemical Name : 6-(((S)-4,11-Diethyl-4-hydroxy-3,14-dioxo-3,4,12,14-tetrahydro-1H-pyrano[3′,4′:6,7]indolizino[1,2-b]quinolin-9-yl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
Smiles : OC1C(OC2=CC=C(N=C(C(N3C4)=CC([C@@](O)(CC)C(OC5)=O)=C5C3=O)C4=C6CC)C6=C2)OC(C(O)=O)C(O)C1O
Inchi : InChI=1/C32H38N4O5/c1-3-22-23-16-21(41-31(38)35-14-10-20(11-15-35)34-12-6-5-7-13-34)8-9-27(23)33-29-24(22)18-36-28(29)17-26-25(30(36)37)19-40-32(26,39)4-2/h8-9,16-17,20,39H,3-7,10-15,18-19H2,1-2H3
Technical Data
Reference
RP-HPLC method development and validation for the simultaneous estimation of Irinotecan hydrochloride and Capecitabine in Active Pharmaceutical Ingredients (APIs)
By Vijaya Jyothi, M.; Bhargav, E.; Keerthana, B.; Varalakshmi, Devi K.nFrom International Journal of Research in Pharmaceutical Sciences (Madurai, India) (2018), 9(1), 63-67
Method development, validation and forced degradation studies of Irinotecan in bulk and pharmaceutical dosage form
By Swathi, Koduru; Farooqui, Tahmeena; Muntaha, Sidra Tul; Ayesha, Syeda Amtul; Shama, Syeda; Siddiqui, Sarah Imam – From World Journal of Pharmacy and Pharmaceutical Sciences (2018), 7(8), 996-1009
RFQ